Stocks · News reference
STAAR Surgical expects preliminary Q2 2026 net sales to top $90 million, driven by strong Americas growth and an inventory rebound in China.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-10 AccNo: 0001193125-26-386662 Size: 190 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $31 to $28.
UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.